Cargando…
European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial
BACKGROUND: Renal failure is a frequent complication of multiple myeloma and when severe is associated with a greatly increased morbidity and mortality. The principal cause of severe renal failure is cast nephropathy, a direct consequence of high concentrations of monoclonal free light chains (FLCs)...
Autores principales: | Hutchison, Colin A, Cook, Mark, Heyne, Nils, Weisel, Katja, Billingham, Lucinda, Bradwell, Arthur, Cockwell, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564897/ https://www.ncbi.nlm.nih.gov/pubmed/18822172 http://dx.doi.org/10.1186/1745-6215-9-55 |
Ejemplares similares
-
Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report
por: Basnayake, Kolitha, et al.
Publicado: (2008) -
Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
por: Hutchison, Colin A, et al.
Publicado: (2012) -
Recent Advances in the Pathogenesis and Management of Cast Nephropathy (Myeloma Kidney)
por: Stringer, Stephanie, et al.
Publicado: (2011) -
High cut-off dialyser haemodialysis in cast nephropathy
por: Li Cavoli, Gioacchino, et al.
Publicado: (2012) -
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study
por: Yadav, Punit, et al.
Publicado: (2020)